Investor Relations

Lotus is dedicated to driving sustainable growth and value through a diversified portfolio, ensuring global access to high-quality healthcare solutions.
Section ImageSection ImageSection Image
Section Image

Why Invest in Lotus?

At Lotus, we believe health is a right, not a privilege. With scientific rigor and operational precision, we tackle complex pharmaceutical challenges to expand the reach of trusted therapies, strengthen market leadership, and create lasting value worldwide. This is how we achieve Confidence in Every Dose and make high‑quality medicines accessible to all.

Financial Strength

Financial Strength

We consistently deliver strong financial results, underpinned by a resilient core business and a two-pronged expansion strategy that drives profitability, market growth, and long-term shareholder value.

Diverse Product Portfolio

Diverse Product Portfolio

Our expanding portfolio includes complex generics with a focus on oncology, along with branded medicines, 505(b)(2) products, biosimilars, and NCEs—positioning Lotus as a strong, diversified global pharmaceutical company with multiple growth drivers.

Global Reach

Global Reach

With our growing presence in key markets worldwide, we are well-positioned to respond to the global demand for affordable healthcare solutions.

We Create Reliable, Long-Term Value

Revenue Increased  14% 2015-2025 CAGR
Revenue Increased
14%
2015-2025 CAGR
EPS Growth 49% 2015-2024 CAGR
EPS Growth
49%
2015-2024 CAGR
Gross Margin 58.8% 2024
Gross Margin
58.8%
2024